Infinity To Present At BIO Investor Forum

October 11, 2018 08:32

CAMBRIDGE, Mass., Oct. 11, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the BIO Investor Forum on Wednesday, October 17, 2018, at 11:15 a.m. PT (2:15 p.m. ET) in San Francisco, CA. A live webcast of the presentation will be available on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.

About Infinity
Infinity is an innovative biopharmaceutical company dedicated to advancing novel cancer treatments. Infinity is advancing IPI-549, a potentially transformative immuno-oncology approach that aims to reprogram tumor-associated macrophages by selectively inhibiting PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Contact:
Stephanie Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com

Cision View original content:http://www.prnewswire.com/news-releases/infinity-to-present-at-bio-investor-forum-300729176.html

SOURCE Infinity Pharmaceuticals, Inc.

Related Stories

Biotech bankruptcies hit a record despite sector’s recovery
SA Breaking News 03/14 14:54 ET
INFI MONDAY DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI
Globe Newswire 10/13 16:45 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI
Globe Newswire 10/11 11:21 ET
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI
Globe Newswire 10/03 15:36 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI
Globe Newswire 10/03 12:28 ET
DEADLINE ALERT for KEY, LYV, APLD, and INFI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire 10/03 12:07 ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Accesswire 10/03 04:30 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Applied Digital, Infinity, and Shift4 and Encourages Investors to Contact the Firm
Globe Newswire 10/02 21:00 ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Infinity Pharmaceuticals, Inc. with Losses of $500,000 to Contact the Firm
Accesswire 10/01 23:45 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI
PR Newswire 09/29 17:22 ET